Malaysia on Saturday mentioned it expects to receive the first batch of the Covid-19 vaccine collectively developed by Pfizer and BioNTech in February, in accordance to a report by nationwide information wire Bernama.
Last month, Malaysia introduced it had agreed to purchase 12.eight million doses of the vaccine, turning into the first nation in Southeast Asia to strike a cope with the US drugmaker.
Under the deal, Pfizer will ship the first a million doses in the first quarter of 2021, with 1.7 million, 5.eight million and 4.three million doses to comply with in subsequent quarters.
Trade Minister Mohamed Azmin Ali mentioned the federal government can be in talks with different pharmaceutical firms to safe extra vaccines.
“The government is making efforts to get a bigger supply of vaccine to meet our needs. The government will take the advice of the Health Ministry regarding the percentage of people who need to be vaccinated,” Mohamed Azmin was quoted as saying by Bernama.
Pfizer and their German companions BioNTech have provide offers with a number of nations together with the United States, Germany, Japan, Canada, Australia and Britain.
They anticipate to produce globally up to 50 million doses of vaccines in 2020 and up to 1.three billion doses in 2021.
More than 150 potential vaccines are being developed and examined globally to cease the Covid-19 pandemic, with 48 in human trials, the WHO says.